Shilong Sun

机构：First Affiliated Hospital of Zhengzhou University · ORCID：0000-0001-8034-9381

发表论文 3 篇 · 总被引 6 次 · h-index 1

代表论文

• Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA (2025 · Journal for ImmunoTherapy of Cancer · 被引 4)
• Indole-3-acetic acid derived from Blautia protects against sepsis-induced acute lung injury (2026 · Frontiers in Immunology · 被引 1)
• Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma (2023 · Clinical and Translational Medicine · 被引 1)